Recent content by starlight

  1. S

    Persistent Tinnitus Spike After Short-Term Clomipramine Use and Possible Congestion

    I have had pre-existing reactive tinnitus for a few years now. I was recently prescribed a tricyclic antidepressant, Clomipramine, for a different issue and took 25 mg for only four days, totaling 100 mg. On the fourth day, I experienced heart palpitations that felt like a heart attack and a...
  2. S

    Did your tinnitus spike from Lexapro subside?

    Did your tinnitus spike from Lexapro subside?
  3. S

    Sudden Onset of Ear Pain and Burning After Hospital Visit Despite Protection

    Did you experience it in one ear or in both ears? Mine is only in one ear. To complicate things, I have also been coughing up mucus and sneezing, so I might be dealing with some kind of infection. Maybe that is causing the issue or making it worse.
  4. S

    Sudden Onset of Ear Pain and Burning After Hospital Visit Despite Protection

    I have had reactive tinnitus for a few years now, along with loudness hyperacusis from acoustic trauma. Until recently, I had not experienced pain sensations or noxacusis. I had to go to the hospital for a completely unrelated issue. I am not sure whether it was the road noise or the noise...
  5. S

    Hi, did your burning in silence ever subside?

    Hi, did your burning in silence ever subside?
  6. S

    Suzetrigine (JOURNAVX, Formerly VX-548) for Pain Hyperacusis (Noxacusis)?

    Like Ambroxol, it appears to target the NaV1.8 sodium channel, which is involved in pain signaling. I’m interested to see how selective Journavx is and whether it has potential uses in non-acute cases.
  7. S

    Suzetrigine (JOURNAVX, Formerly VX-548) for Pain Hyperacusis (Noxacusis)?

    Has anyone tried Suzetrigine for pain hyperacusis or noxacusis? It is being distributed as JOURNAVX by Vertex Pharmaceuticals and was previously labeled VX-548 during clinical trials. The FDA approved it on January 30, 2025. It targets moderate to severe pain by blocking pain signals in the...